Holen Sie sich die Stockscreener-App
136.94
3.26%
4.32
Handel nachbörslich:
136.94
Schlusskurs vom Vortag:
$132.62
Offen:
$134.23
24-Stunden-Volumen:
265.79K
Relative Volume:
0.80
Marktkapitalisierung:
$3.64B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
45.80
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
+8.72%
1M Leistung:
-1.81%
6M Leistung:
-26.08%
1J Leistung:
-17.35%
1-Tages-Spanne:
$134.23
$136.95
1-Wochen-Bereich:
$124.00
$136.95
52-Wochen-Spanne:
$122.80
$219.34
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
136.94 | 3.64B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report? - Yahoo Finance
Exploring Three High Growth Tech Stocks In The US Market - simplywall.st
H.C. Wainwright maintains Krystal Biotech stock Buy rating at ASCO 2025 - Investing.com Nigeria
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
How To Trade (KRYS) - news.stocktradersdaily.com
Krystal Biotech Reports Promising Results for KB707 Trial - TipRanks
Implied Volatility Surging for Krystal Biotech Stock Options - TradingView
Krystal Biotech Enters Oversold Territory (KRYS) - Nasdaq
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Lazard Asset Management LLC Sells 922 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
D. E. Shaw & Co. Inc. Trims Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Why We're Not Concerned Yet About Krystal Biotech, Inc.'s (NASDAQ:KRYS) 26% Share Price Plunge - simplywall.st
Bank of America Corp DE Has $11.88 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech stock hits 52-week low at $127.33 By Investing.com - Investing.com South Africa
Krystal Biotech Holds Annual Stockholders Meeting - MSN
Krystal Biotech stock hits 52-week low at $127.33 - Investing.com
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Cut by BNP Paribas Financial Markets - Defense World
Citigroup Lowers Krystal Biotech (NASDAQ:KRYS) Price Target to $155.00 - Defense World
Krystal Biotech (KRYS) Price Target Lowered by Citigroup | KRYS Stock News - GuruFocus
The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Experts - Benzinga
Krystal Biotech (KRYS) Sees Price Target Cut Amid Sales Forecast Adjustment | KRYS Stock News - GuruFocus
H.C. Wainwright maintains Buy on Krystal Biotech shares By Investing.com - Investing.com Nigeria
Transcript : Krystal Biotech, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 11 - marketscreener.com
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat
Krystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
Krystal Biotech Expands Gene Therapy Platform - TipRanks
How the (KRYS) price action is used to our Advantage - news.stocktradersdaily.com
FY2025 EPS Estimates for Krystal Biotech Lowered by Analyst - Defense World
Cantor Fitzgerald Predicts Krystal Biotech FY2025 Earnings - Defense World
Q4 EPS Estimates for Krystal Biotech Lifted by HC Wainwright - Defense World
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey
10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey
H.C. Wainwright maintains Buy on Krystal Biotech shares - Investing.com Australia
Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates - MSN
Krystal Biotech "insulated" by domestic manufacturingPittsburgh Business Times - The Business Journals
Krystal Biotech (KRYS) Price Target Lowered by Guggenheim | KRYS Stock News - GuruFocus
Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target - GuruFocus
Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target | KRYS Stock News - GuruFocus
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2025 Earnings Call Transcript - Insider Monkey
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference - The Manila Times
Krystal Biotech (KRYS) Maintains Buy Rating and Price Target | KRYS Stock News - GuruFocus
Krystal Biotech Q1 Earnings and Sales Miss Estimates, Stock Down - MSN
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Rec - GuruFocus
Earnings call transcript: Krystal Biotech misses Q1 2025 EPS forecast, stock drops 14% - Investing.com Nigeria
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Krystal Biotech Reports Strong Q1 2025 Results - TipRanks
Decoding Krystal Biotech Inc (KRYS): A Strategic SWOT Insight - GuruFocus
Krystal Biotech outlines 2025 global launch strategy with $88.2M Q1 VYJUVEK revenue - MSN
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Krystal Biotech Inc-Aktie (KRYS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Krishnan Suma | President, R&D |
Mar 13 '25 |
Sale |
177.79 |
25,000 |
4,444,761 |
1,463,711 |
| Krishnan Krish S | President and CEO |
Mar 13 '25 |
Sale |
177.79 |
25,000 |
4,444,763 |
1,533,056 |
| Krishnan Krish S | President and CEO |
Mar 13 '25 |
Sale |
177.79 |
25,000 |
4,444,761 |
1,463,711 |
1.21%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):